AcelRx Pharmaceuticals (ACRX) Posts Narrower than Expected Q4 Loss of 33c/Share

Article Stock Quotes (1) Comments (0)

AcelRx Pharmaceuticals (NASDAQ: ACRX) reported Q4 EPS of ($0.33), $0.06 better than the analyst estimate of ($0.39).

For earnings history and earnings-related data on AcelRx Pharmaceuticals (ACRX) click here.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
• Stage Stores, Inc. (SSI) Posts Surprise Q1 Loss of 2c/Share
• Wal-mart (WMT) Posts Q1 EPS of $1.14; U.S. Comps Down 1.4%; Guides Q2 EPS

Create E-mail Alert Related Categories

Earnings

Related Entities

Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?